The weekly litigation news digest is live. Subscribe now

IP Verse

Stable, Injectable Noradrenaline Solutions Free Of Antioxidants - EP4051251

The patent EP4051251 was granted to Sintetica on Aug 23, 2023. The application was filed on Sep 29, 2021 under application number EP21783523A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4051251

SINTETICA
Application Number
EP21783523A
Filing Date
Sep 29, 2021
Status
Granted And Under Opposition
Jul 21, 2023
Publication Date
Aug 23, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
ZINNERMay 17, 2024ZINNERADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS10251848
DESCRIPTIONUS2005070613
DESCRIPTIONUS2016058715
DESCRIPTIONWO2015128418
DESCRIPTIONWO2018140894
INTERNATIONAL-SEARCH-REPORTUS10653646
INTERNATIONAL-SEARCH-REPORTUS2005070613
INTERNATIONAL-SEARCH-REPORTUS2017049720
OPPOSITIONCN109381457
OPPOSITIONUS2005070613
OPPOSITIONUS2017049720
OPPOSITIONUS2017304445
OPPOSITIONWO2019057918
OPPOSITIONWO2019183416

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents